Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling.

Singh SP, Pillai SY, de Bruijn MJW, Stadhouders R, Corneth OBJ, van den Ham HJ, Muggen A, van IJcken W, Slinger E, Kuil A, Spaargaren M, Kater AP, Langerak AW, Hendriks RW.

Oncotarget. 2017 May 26;8(42):71981-71995. doi: 10.18632/oncotarget.18234. eCollection 2017 Sep 22.

2.

CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.

van Attekum MHA, van Bruggen JAC, Slinger E, Lebre MC, Reinen E, Kersting S, Eldering E, Kater AP.

Haematologica. 2017 Dec;102(12):2069-2076. doi: 10.3324/haematol.2016.157206. Epub 2017 Sep 29.

3.

Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition.

Slinger E, Thijssen R, Kater AP, Eldering E.

Leukemia. 2017 Dec;31(12):2601-2607. doi: 10.1038/leu.2017.129. Epub 2017 May 2.

PMID:
28462919
4.

Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.

van Attekum MHA, Terpstra S, Slinger E, von Lindern M, Moerland PD, Jongejan A, Kater AP, Eldering E.

Oncogene. 2017 Jun 29;36(26):3651-3660. doi: 10.1038/onc.2016.515. Epub 2017 Feb 13.

5.

Erratum: Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signaling.

Wensveen FM, Slinger E, van Attekum MH, Brink R, Eldering E.

Sci Rep. 2017 Jan 12;7:39366. doi: 10.1038/srep39366. No abstract available.

6.

Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signaling.

Wensveen FM, Slinger E, van Attekum MH, Brink R, Eldering E.

Sci Rep. 2016 Oct 20;6:35673. doi: 10.1038/srep35673. Erratum in: Sci Rep. 2017 Jan 12;7:39366.

7.

Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling.

Peperzak V, Slinger E, Ter Burg J, Eldering E.

Cell Death Differ. 2017 Jan;24(1):111-119. doi: 10.1038/cdd.2016.105. Epub 2016 Sep 30.

8.

Chronic lymphocytic leukemia development is accelerated in mice with deficiency of the pro-apoptotic regulator NOXA.

Slinger E, Wensveen FM, Guikema JE, Kater AP, Eldering E.

Haematologica. 2016 Sep;101(9):e374-7. doi: 10.3324/haematol.2016.142323. Epub 2016 Jun 13. No abstract available.

9.

Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors.

Thijssen R, Slinger E, Weller K, Geest CR, Beaumont T, van Oers MH, Kater AP, Eldering E.

Haematologica. 2015 Aug;100(8):e302-6. doi: 10.3324/haematol.2015.124560. Epub 2015 May 8. No abstract available.

10.

IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.

Chen L, He Z, Slinger E, Bongers G, Lapenda TLS, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N, Gordon RE, Ochando JC, Oukka M, Iuga AC, Chensue SW, Blander JM, Furtado GC, Lira SA.

Mucosal Immunol. 2015 Mar;8(2):390-402. doi: 10.1038/mi.2014.77. Epub 2014 Aug 27.

11.

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.

Kater AP, Spiering M, Liu RD, Doreen Te Raa G, Slinger E, Tonino SH, Beckers MM, Daenen S, Doorduijn JK, Lankheet NA, Luijks DM, Eldering E, van Oers MH.

Leuk Res. 2014 Jan;38(1):34-41. doi: 10.1016/j.leukres.2013.10.004. Epub 2013 Oct 28.

PMID:
24238639
12.

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model.

Lascano V, Guadagnoli M, Schot JG, Luijks DM, Guikema JE, Cameron K, Hahne M, Pals S, Slinger E, Kipps TJ, van Oers MH, Eldering E, Medema JP, Kater AP.

Blood. 2013 Dec 5;122(24):3960-3. doi: 10.1182/blood-2013-04-497693. Epub 2013 Oct 7.

13.

Constitutive β-catenin signaling by the viral chemokine receptor US28.

Langemeijer EV, Slinger E, de Munnik S, Schreiber A, Maussang D, Vischer H, Verkaar F, Leurs R, Siderius M, Smit MJ.

PLoS One. 2012;7(11):e48935. doi: 10.1371/journal.pone.0048935. Epub 2012 Nov 8.

14.

A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Bongers G, Muniz LR, Pacer ME, Iuga AC, Thirunarayanan N, Slinger E, Smit MJ, Reddy EP, Mayer L, Furtado GC, Harpaz N, Lira SA.

Gastroenterology. 2012 Sep;143(3):730-740. doi: 10.1053/j.gastro.2012.05.034. Epub 2012 May 26.

15.

HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis.

Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, Lira SA, Söderberg-Nauclér C, Smit MJ.

Sci Signal. 2010 Aug 3;3(133):ra58. doi: 10.1126/scisignal.2001180.

16.

Problem-solving courts in Canada: A review and a call for empirically-based evaluation methods.

Slinger E, Roesch R.

Int J Law Psychiatry. 2010 Sep-Oct;33(4):258-64. doi: 10.1016/j.ijlp.2010.06.008. Review.

PMID:
20663560
17.

Herpesvirus-encoded GPCRs rewire cellular signaling.

Slinger E, Langemeijer E, Siderius M, Vischer HF, Smit MJ.

Mol Cell Endocrinol. 2011 Jan 15;331(2):179-84. doi: 10.1016/j.mce.2010.04.007. Epub 2010 Apr 14. Review.

PMID:
20398729
18.

The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.

Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK, Slinger E, Schreiber A, Michel D, Tensen CP, van Dongen GA, Leurs R, Smit MJ.

Cancer Res. 2009 Apr 1;69(7):2861-9. doi: 10.1158/0008-5472.CAN-08-2487. Epub 2009 Mar 24.

Supplemental Content

Loading ...
Support Center